Diwakar Davar, M.B.B.S., is a medical oncologist and hematologist specializing in immuno-oncology. He is the Clinical Director of the Melanoma and Skin Cancer Program at UPMC Hillman Cancer Center and an Associate Professor in the Division of Hematology/Oncology at the University of Pittsburgh, where he also serves on the Cancer Immunology and Immunotherapy research faculty. Clinically, his work centers on cutaneous oncology, immuno-oncology, and early-phase therapeutics. His research focuses on translational immuno-oncology, tumor–immune–microbiome interactions, and mechanisms and biomarkers of resistance to immunotherapy, with a track record in developing next-generation immune modulators and leading early-phase trials. A nationally recognized leader, Davar has been honored with awards such as Castle Connolly Top Doctor, the Sy Holzer Endowed Immunotherapy Research Award, and the PNC Elsie Hillman Distinguished Scholar Award. He has served as institutional principal investigator for multiple first-in-human immunotherapy studies and has been invited as a plenary speaker at oncology research forums. He earned his medical degree from the National University of Singapore, completed his internal medicine residency at UPMC Presbyterian, and pursued fellowship training in hematology and oncology at the University of Pittsburgh Affiliated Hospitals.
Clinical Director, Melanoma and Skin Cancer Program
Medical School
2005
Residency
2009 – 2012
Fellowship
2013 – 2016